Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models.

Shoemaker AR, Mitten MJ, Adickes J, Ackler S, Refici M, Ferguson D, Oleksijew A, O'Connor JM, Wang B, Frost DJ, Bauch J, Marsh K, Tahir SK, Yang X, Tse C, Fesik SW, Rosenberg SH, Elmore SW
Clin Cancer Res. 2008 14 (11): 3268-77

PMID: 18519752 · DOI:10.1158/1078-0432.CCR-07-4622

MeSH Terms (12)

Aniline Compounds Animals Antineoplastic Agents Carcinoma, Small Cell Dose-Response Relationship, Drug Humans Lung Neoplasms Mice Mice, Nude Proto-Oncogene Proteins c-bcl-2 Sulfonamides Xenograft Model Antitumor Assays

Connections (1)

This publication is referenced by other Labnodes entities: